Publicaciones en colaboración con investigadores/as de Universitat de València (9)

2023

  1. Atherogenic dyslipidaemia in type 2 diabetes mellitus: The PREDISAT study

    Lipids, Vol. 58, Núm. 4, pp. 197-206

2020

  1. Atherogenic Dyslipidaemia 2019. Consensus document of the Atherogenic Dyslipidaemia Group of the Spanish Arteriosclerosis Society

    Clinica e Investigacion en Arteriosclerosis, Vol. 32, Núm. 3, pp. 120-125

  2. Triglycerides, HDL cholesterol and atherogenic dyslipidaemia in the 2019 European guidelines for the management of dyslipidaemias

    Clinica e Investigacion en Arteriosclerosis, Vol. 32, Núm. 5, pp. 209-218

2019

  1. Standards for global cardiovascular risk management arteriosclerosis

    Clinica e Investigacion en Arteriosclerosis, Vol. 31, pp. 1-43

2018

  1. COSMIC project: Consensus on the objectives of the metabolic syndrome in clinic

    Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Vol. 11, pp. 683-697

2012

  1. Documento Abordaje de la dislipidemia. Sociedad Española de Arteriosclerosis (parte III)

    Clinica e Investigacion en Arteriosclerosis, Vol. 24, Núm. 2, pp. 102-107

2011

  1. Prevalence of metabolic syndrome and cardiovascular disease in a hypertriglyceridemic population

    European Journal of Internal Medicine, Vol. 22, Núm. 2, pp. 177-181

  2. Prevalencia del síndrome metabólico y de sus componentes en pacientes con síndrome coronario agudo

    Revista Espanola de Cardiologia, Vol. 64, Núm. 7, pp. 579-586

2004

  1. Significance of high density lipoprotein-cholesterol in cardiovascular risk prevention: Recommendations of HDL Forum

    American Journal of Cardiovascular Drugs, Vol. 4, Núm. 5, pp. 299-314